Chemotherapy for high-risk localized prostate cancer.
Nakabayashi
Mari
M
Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street D1230, Boston, MA 02115, USA.
Oh
William K
WK
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant; D000077143:Docetaxel; D006801:Humans; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage*; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel; D008942:Mitoxantrone